Abstract
Together with pain and fever, fatigue is known as one of the living body’s three main alarms, an important signal to the body for the maintenance of life and health. The body usually recovers from fatigue with rest, but a feeling of fatigue may persist for a long period. When the symptoms and duration of fatigue exceed the usual fatigued feeling, the body’s immune function deteriorates making it prone to psychological disorders such as depression, as well as a range of infectious diseases. Few Western medications are useful for this kind of fatigue. There are, however, many useful formulae among Kampo medications. The introduction below first gives a brief explanation of qi (Ki), blood and fluid (Kiketsusui), and the “patterns” of Kampo medical diagnosis before discussing the Kampo medical diagnoses “qi (Ki) deficiency (Kikyo), blood deficiency (Kekkyo), and dual deficiency of qi (Ki) and blood (Kiketsu Ryokyo)” and how fatigue was perceived in olden times. The “Discussion” part focuses on clinical reports on two prominent Kampo medications, hochuekkito (補中益気湯) and juzentaihoto (十全大補湯).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Yamakawa J (2012) Efficacy evaluation of kampo medicine in a mouse model of chronic fatigue syndrome. In: Motoo Y (ed) Traditional medicine new research. Nova Science Publishers, Inc, New York, pp 83–122
Chen R, Moriya J, Yamakawa J et al (2010) Traditional Chinese medicine for chronic fatigue syndrome. Evid Based Complement Alternat Med 7:3–10
Otsuka K, Otsuka Y, Watanabe K (2000) Practical symptom-based kampo therapy (Revised), 5th edn. Nanzando, Tokyo, pp 231–232
Matsuda K (1992) Practice of kampo treatment – diagnosis and treatment, 74(11). Shindan To Chiryo Sha Inc, Osaka, pp 2278–2282
Tatsuno K (1979) An outline of kampo medicine 1 (1). Yukonsha, Kyoto, pp 12–14
Terasawa K (2005) Kampo patterns (Sho): a patient-centered, not disease-centered, diagnostic system. Kagaku 75. Iwanami Shoten Publishers, Tokyo, pp 821–823
Matsuda K (1980) “Yoshimasu Nangai”, an exposition of his compendium, vol 37. Meicho Shuppan, Osaka, p 16
Yoshimasu N Medical Patterns – Modern Kampo Medicine Compendium vol 37 p 134
Terasawa K (2006) On the formation of Chinese great classic “shokanron”, and its specificity. Kampo Med 57:799–804
The Japan Kampo Medicine Association – Academic Committee (2000) Shanhan Zabinglun (Treatise on Cold Damage Disorders), 3rd edn. Toyo Gakujutsu Shuppansha, Chiba
Mayanagi M (1989) A bibliographical introduction to Neiwaishangbianhuolun (Treatise on clarification of perplexities about internal and external damage), Piweilun (Treatise on the spleen and stomach), and Lanshimicang (Secret records of the orchid chamber), Kosoto H, Mayanagi M (eds). Wakoku Kanseki Isho Shusei vol 6 Commentary. Enterprise, Tokyo, p 22–36
Mayanagi M, Kosoto H (1990) Medical texts in Jin period. J Tradit Sino-Jpn Med 11:495–501
Mayanagi M (1995) The history of a Chinese herbal prescription Bu-Zhong-Yi-Qi-Tang. J Tradit Sino-Jpn Med 16:501–507
Yamakawa J, Motoo Y, Moriya J et al (2013) Role of kampo medicine in integrative cancer therapy. Evid Based Complement Alternat Med 2013:570848
Yamakawa J, Motoo Y, Moriya J et al (2013) Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients. Evid Based Complement Alternat Med 2013:746486
Yamakawa J, Moriya J, Takeuchi K et al (2013) Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence. Evid Based Complement Alternat Med 2013:943075
Yamakawa J, Moriya J, Takahashi T et al (2010) A Kampo medicine, Boi-ogi-to, inhibits obesity in ovariectomized rats. Evid Based Complement Alternat Med 7:87–95
Abe K (1989) The effects of hochuekkito for side effects of chemotherapy after cancer surgery. Prog Med 9:2916–2922
Ohara T, Onda M, Futagawa S et al (1993) Study of the usefulness of combining hochuekkito and ninjinyoeito with Tegafur. Jpn Pharmacol Ther 21:4423–4434
Ohno S (1988) Effects of a traditional Chinese medicine “hochuekki-to” on natural killer activity. Arerugi 37:107–114
Watanabe A, Hasegawa S (1992) Effect of combined Kampo medicines as adjuvant therapy for pulmonary tuberculosis. Jpn Med J 3553:76–77
Suzuki J, Arata S, Sugiyama M (2002) Improvement of immunity and nutrition by hochuekkito in immune-compromised hosts–for the control of MRSA. Prog Med 22:1362–1363
Irie K, Tateishi M, Yuu H et al (1992) Clinical effects of hochuekkito on gastroptosis symptoms. J N Remedies Clin 41:423–432
Tomita H, Chiba S, Kadowaki J et al (1997) Clinical effects of hochuekkito on pediatric orthostatic disturbance. J Pediatr Pract 60:162–167
Kuratsune H, Yamaguchi K, Tokumine Y (1997) Kampo formulations for chronic fatigue syndrome–clinical effects of hochuekkito. Jpn J Clin Exp Med 74:1837–1845
Kuratsune H, Nakatomi Y, Kagura M et al (2010) Clinical effectiveness of twice daily hochuekkito for chronic fatigue syndrome patients. Prog Med 30:505–510
Moriya J (2006) Establishment of murine model for chronic fatigue syndrome and efficacy of kampo medicine on daily activity. J Kanazawa Med Univ 31:263–268
Chen R, Moriya J, Yamakawa J et al (2008) Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). Neurochem Res 33:1759–1767
Matsuzawa K, Nakano H, Oonishi Y (1997) Effects of hochuekkito for sleep-disordered breathing―a preliminary study using pulse oximetry. Jpn J Chest Dis 56:846–849
Ping L, Takase K, Mukobayashi M et al (1996) Clinical effects of traditional Chinese herbal medicine “Hochuekkito” on male infertility. Advances Obstet Gynecol 48:406–410
Ohara K, Nishimoto M, Miyazato K et al (1994) Effects of hochuekkito (TJ-41) for anorexia. Prog Med 14:1705–1712
Kurokawa T, Imai J, Tamakuma M (1989) Improvement of anorexia, nausea and vomiting, and lassitude, side effects of anti-cancer drug administration. “Effects of juzentaihoto in preventing anti-cancer drug side effects–A clinical immunology study”. Biotherapy 3:789–795
Suzuki S, Abe R, Nomizu T et al (1995) Effect of juzentaihoto (TJ-48) on leukopenia in patients receiving cancer chemotherapy. Prog Med 15:1968–1971
Niwa K, Hashimoto M, Tamaya T (2000) Effects of Juzen-taiho-to and M-CSF on thrombocytopenia induced by anti-cancer drugs in gynecologic malignancies. Jpn J Orient Med 51:447–454
Yamada T (1992) Clinical study of juzen-taiho-to administration for postoperative esophageal carcinoma, gastric carcinoma, and colorectal carcinoma – Influence of surgical intervention and postoperative chemotherapy on cell mediated immunity. J Med Pharm Soc WAKAN-YAKU 9:157–164
Rino Y, Yukawa N, Yamada R et al (2013) Improvement of adverse effects by juzen-taiho-to in the chemotherapy for patients with advanced or recurrent gastric cancer. J Jpn Coll Surg 38:62–66
Konno H, Maruo Y, Baba S et al (1997) Improvement of immunocompetence with combined use of juzendaihoto in adjuvant chemotherapy after gastric cancer surgery. Biotherapy 11:193–199
Kosaka A, Kamiya T, Sumiyama M et al (1994) Usefulness of TSUMURA Juzentaihoto (TJ-48) for reducing adverse effects of anticancer drugs and improving QOL. Prog Med 14:2259–2264
Adachi I (1990) Supporting therapy with Shi Quan Da Bu Tang in advanced breast cancer patients. Biomed Res 11:25–31
Tanaka Y, Hashimoto S (1988) Effects of TSUMURA Juzentaihoto on various complaints occurring as adverse reactions during radiotherapy. JAMA 6:70–71
Tarao K, Okamoto T, Miyakawa K et al (2003) Effect of Juzen-taiho-to on the serum alanine aminotransferase levels in patients with HCV-associated chronic hepatitis or liver cirrhosis. Jpn J Orient Med 54:191–198
Tarao K, Sakamoto Y, Ueno M et al (2010) Juzentaihoto (TJ-48) may be an important and effective anti-inflammatory agent for intractable cases of patients with HCV-associated chronic liver-diseases. Jpn J Orient Med 61:1–8
Sho Y, Fujisaki K, Sakashita H et al (2004) Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol 39:1202–1204
Higuchi K, Shimizu Y, Yasumura S et al (2002) Preventive effect of liver carcinogenesis by juzen-taiho-to in the patients with liver cirrhosis. Kan-Tan-Sui 44:341–346
Aoe H, Ota M, Kawahara N et al (2003) Efficacy of using juzentaihoto to augment preoperative autologous blood donation. J Med Technol 47:395–399
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Yamakawa, Ji., Moriya, J., Kobayashi, J. (2016). Fatigue and Kampo (Japanese Herbal) Medicines: Hochuekkito and Juzentaihoto. In: Inui, A. (eds) Herbal Medicines. Methods in Pharmacology and Toxicology. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-4002-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-4002-8_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-4000-4
Online ISBN: 978-1-4939-4002-8
eBook Packages: Springer Protocols